Mayukh Sukhatme
CIK 1750050 · President & CIO · last filed 2026-11-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ROIV price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
7TH FLOOR, 50 BROADWAY
LONDON SW1H 0DB
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ROIV | President & CIO | 20,054,401 | $39.24 | $786.93M | -$124.75M | 18 | 2026-11-12 |
| Roivant Sciences Ltd. (ROIVW) Delisted | Pres&Chief Investment Officer | 4,847,658 | $2.75 | $13.33M | $0 | 4 | 2023-08-29 |
Holdings By Holder
| Symbol | Holder | Shares | Share of Total | Reported |
|---|---|---|---|---|
| ROIV | Direct | 18,396,703 | 91.7% | 2026-11-12 |
| By LLC | 1,657,698 | 8.3% | 2024-07-30 | |
| Total | 20,054,401 | |||
| ROIVW | Direct | 3,189,960 | 65.8% | 2023-08-29 |
| By LLC | 1,657,698 | 34.2% | 2023-08-29 | |
| Total | 4,847,658 |
Recent Filings · Page 4 of 4
39 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-12-05 | ROIV | Other (J) | −3,651,985 | -$44.57M | EDGAR |
| 2024-07-30 | ROIV | Grant (A) | +18,836,547 | $0 | EDGAR |
| 2024-04-02 | ROIV | Mixed10b5-1 | +362,870 | -$3.86M | EDGAR |
| 2023-12-29 | ROIV | Exer (M) | +71,365 | $0 | EDGAR |
| 2023-09-29 | ROIV | Exer (M) | +27,790 | $0 | EDGAR |
| 2023-08-29 | Roivant Sciences Ltd. (ROIVW) Delisted | Exer (M) | +22,565 | $0 | EDGAR |
| 2023-07-31 | Roivant Sciences Ltd. (ROIVW) Delisted | Exer (M) | +43,212 | $0 | EDGAR |
| 2023-05-31 | Roivant Sciences Ltd. (ROIVW) Delisted | Exer (M) | +99,458 | $0 | EDGAR |
| 2022-04-22 | Roivant Sciences Ltd. (ROIVW) Delisted | Grant (A) | — | $0 | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).